PRTA Q3 2017 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$219,000-23.4% YoY

Gross Profit

-$41M-18765.3% margin

Operating Income

-$54M-24444.7% margin

Net Income

-$52M-23924.2% margin

EPS (Diluted)

$-1.37

QoQ Revenue Growth

-99.2%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$538M

Total Liabilities

$91M

Stockholders' Equity

$446M

Cash & Equivalents

$456M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$219,000	$286,000	-23.4%
Gross Profit	-$41M	-$27M	-54.8%
Operating Income	-$54M	-$43M	-25.4%
Net Income	-$52M	-$43M	-21.2%